|
FINAL GUIDANCE RELEASED ON NUCLEIC ACID TESTS
The FDA published a final guidance Oct. 28 addressing the use of nucleic acid tests (NATs) to screen blood donors for HIV-1 and hepatitis C virus (HCV). This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives